Institutional Ownership Mereo Biopharma Group PLC (MREO)
This table provides information about the institutional ownership of Mereo Biopharma Group PLC (MREO). We have compiled data on the 100 institutions that hold shares in the stock, with a total of 111 Million shares, which have been reported (via 13F filing form) to have a value of $250 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
22,735,121
shares
|
$51.2 Million
0.03% of portfolio
|
Q1 2025
Added 32.78%
|
|
|
Rubric Capital Management LP
New York, NY |
May 14, 2025 Q1 2025 |
15,307,347
shares
|
$34.4 Million
0.99% of portfolio
|
Q2 2024
Added 12.94%
|
|
|
Mangrove Partners
New York, NY |
May 15, 2025 Q1 2025 |
8,636,485
shares
|
$19.4 Million
3.05% of portfolio
|
Q4 2024
Reduced 1.07%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
7,819,863
shares
|
$17.6 Million
1.11% of portfolio
|
Q1 2025
Added 53.4%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
May 15, 2025 Q1 2025 |
6,710,429
shares
|
$15.1 Million
0.38% of portfolio
|
Q2 2024
New holding
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2025 Q1 2025 |
6,684,247
shares
|
$15 Million
0.9% of portfolio
|
Q1 2025
Reduced 30.37%
|
|
|
Alkeon Capital Management LLC
New York, NY |
May 14, 2025 Q1 2025 |
4,698,100
shares
|
$10.6 Million
0.02% of portfolio
|
Q2 2024
Added 10.85%
|
|
|
683 Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
4,635,000
shares
|
$10.4 Million
0.84% of portfolio
|
Q1 2025
Added 1.87%
|
|
|
Clearline Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
3,217,894
shares
|
$7.24 Million
0.47% of portfolio
|
Q4 2024
Reduced 0.81%
|
|
|
Tejara Capital LTD
London, X0 |
May 13, 2025 Q1 2025 |
2,521,324
shares
|
$5.67 Million
2.19% of portfolio
|
Q1 2025
Added 8.81%
|
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
2,188,354
shares
|
$4.92 Million
0.01% of portfolio
|
Q1 2025
New holding
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
2,179,642
shares
|
$4.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 38.67%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
2,125,920
shares
|
$4.78 Million
0.0% of portfolio
|
Q1 2025
Added 0.29%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
1,700,756
shares
|
$3.83 Million
0.01% of portfolio
|
Q1 2025
Reduced 80.48%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
1,591,056
shares
|
$3.58 Million
0.02% of portfolio
|
Q1 2025
Added 222.14%
|
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
1,551,082
shares
|
$3.49 Million
0.08% of portfolio
|
Q3 2021
Added 48.46%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
1,350,471
shares
|
$3.04 Million
0.0% of portfolio
|
Q1 2025
Added 13.54%
|
|
|
Great Point Partners LLC
Greenwich, CT |
May 15, 2025 Q1 2025 |
1,275,000
shares
|
$2.87 Million
1.77% of portfolio
|
Q1 2025
Added 10.87%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
964,900
shares
|
$2.17 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
947,986
shares
|
$2.13 Million
0.01% of portfolio
|
Q1 2025
Added 53.2%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
932,021
shares
|
$2.1 Million
0.0% of portfolio
|
Q1 2025
Reduced 64.8%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
876,961
shares
|
$1.97 Million
0.08% of portfolio
|
Q1 2025
Reduced 19.21%
|
|
|
Integral Health Asset Management, LLC
|
May 15, 2025 Q1 2025 |
800,000
shares
|
$1.8 Million
0.21% of portfolio
|
Q1 2025
Reduced 20.0%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
May 15, 2025 Q1 2025 |
791,815
shares
|
$1.78 Million
3.38% of portfolio
|
Q1 2025
Added 1.6%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
767,744
shares
|
$1.73 Million
0.0% of portfolio
|
Q1 2025
Reduced 11.38%
|